Comparison
10p13 P14 Deletion Syndrome Cn379618 vs 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
Clinical comparison between 10p13 P14 Deletion Syndrome CN379618 and 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete CN042980 for differential diagnosis and treatment planning.
10p13 P14 Deletion Syndrome Cn379618
A rare chromosomal disorder caused by deletion of genetic material on chromosome 10. It can affect development, facial features, and organ function. Management involves multidisciplinary care to address specific symptoms and provide developmental support.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
A rare enzyme deficiency affecting hormone production, leading to low sex hormones and elevated blood pressure. Lifelong hormone replacement therapy is typically needed. Ongoing medical monitoring helps manage associated health concerns.
6 comparison axes
Onset
10p13 P14 Deletion Syndrome Cn379618
0-0
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
0-null
Onset patterns differ
Severity
10p13 P14 Deletion Syndrome Cn379618
severe
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
severe
Different severity levels
Chronic
10p13 P14 Deletion Syndrome Cn379618
Chronic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
Chronic
Differing course
Communicable
10p13 P14 Deletion Syndrome Cn379618
No
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
No
Different transmission
Body System
10p13 P14 Deletion Syndrome Cn379618
congenital
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
endocrine
Same/different system
Category
10p13 P14 Deletion Syndrome Cn379618
genetic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
endocrine
Different category
Bottom line
10p13-p14-deletion-syndrome-CN379618 and 17-alpha-hydroxylase-17-20-lyase-deficiency-combined-complete-CN042980 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 10p13 P14 Deletion Syndrome Cn379618 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 | Discriminating power |
|---|---|---|---|
| Developmental and facial features | May include developmental concerns and characteristic facial features; exact features vary and are not fully established here. | Not primarily a developmental-facial syndrome; sex-hormone deficiency may affect puberty and sexual development. | High |
| Blood pressure | Hypertension is not established by the supplied description. | Elevated blood pressure is a described feature and needs monitoring. | High |
| Sex-hormone effects | Not described as a primary hormone-production disorder. | Low sex hormones are described; lifelong replacement is typically needed. | High |
When to favor each condition
Choose 10p13 P14 Deletion Syndrome Cn379618 when
Congenital developmental pattern
Consider when developmental, facial, or multisystem congenital findings suggest a chromosomal deletion.
Moderate
Genetic testing shows 10p deletion
A confirmed deletion involving 10p13-p14 supports this diagnosis over an enzyme deficiency.
High
No endocrine pattern
Absence of low sex hormones and hypertension makes the enzyme deficiency less likely, but does not prove the deletion.
Low
Choose 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 when
Hypertension with low sex hormones
This combination matches the supplied endocrine description better than a chromosomal deletion.
Moderate
Disordered puberty or sexual development
Sex-hormone deficiency raises suspicion, but confirmation requires endocrine and genetic evaluation.
Moderate
CYP17A1-related diagnosis confirmed
A confirmed combined complete enzyme deficiency establishes the right condition.
High
How key tests differ
| Test | 10p13 P14 Deletion Syndrome Cn379618 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify deletion of material on chromosome 10. | Not expected to diagnose the enzyme deficiency. | A relevant deletion supports the left diagnosis; normal chromosomes do not exclude the right condition. |
| Steroid and sex-hormone profile | No specific pattern is established here. | Expected to reflect impaired sex-hormone production; exact cutoffs are not stated. | Abnormal results suggest an endocrine disorder but are not themselves a diagnosis. |
| Blood-pressure assessment | No characteristic result is established. | May show elevated blood pressure requiring follow-up. | Hypertension is a finding, not proof of the enzyme deficiency. |
Prognosis comparison
10p13 P14 Deletion Syndrome Cn379618
- Outcome
- Chronic and potentially severe, but individual outcome is not established.
- Factors
- Extent of deletion and affected development or organs.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Complete Cn042980
- Outcome
- Chronic and potentially severe, generally requiring lifelong hormone care.
- Factors
- Hormone deficiency, blood-pressure control, and monitoring adherence.
Time frame: Lifelong; onset data are incomplete.
Prognosis cannot be quantified from the supplied information.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Developmental support may be needed; severity varies. Not the primary described complication. Specific outcomes are not established and require individual assessment. |
| Organ dysfunction | Organ function may be affected, depending on the deletion. Main described concerns are hormonal and blood-pressure related. Do not assume a particular organ complication without evaluation. |
| Hormonal and cardiovascular effects | Not established as characteristic. Low sex hormones and elevated blood pressure require lifelong monitoring. Treatment doses and complication rates are not provided. |
Patient education highlights
- HighDifferent causes
One is a chromosomal deletion; the other is a rare hormone-enzyme deficiency. They are not contagious.
- HighSpecialist care
Both need individualized specialist care. Hormone replacement and monitoring are typical for the enzyme deficiency.
- MediumTest meaning
An abnormal test is not automatically a diagnosis. Results should be interpreted by a clinician.